315 results on '"Feuer, Eric J"'
Search Results
2. Estimating life expectancy adjusted by self-rated health status in the United States: national health interview survey linked to the mortality
3. Toward real-time reporting of cancer incidence: methodology, pilot study, and SEER Program implementation.
4. Assessing racial, ethnic, and nativity disparities in US cancer mortality using a new integrated platform.
5. Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening
6. On the Analysis of Discrete Time Competing Risks Data
7. Genetic Simulation Tools for Post‐Genome Wide Association Studies of Complex Diseases
8. Lorenz Curves and Gini Coefficient Analyses Indicate Inefficiencies in Esophageal Adenocarcinoma Screening
9. NordICC Trial Results in Line With Expected Colorectal Cancer Mortality Reduction After Colonoscopy: A Modeling Study
10. Ranking composite Cancer Burden Indices for geographic regions : point and interval estimates
11. Urban/Rural Differences in Breast and Cervical Cancer Incidence: The Mediating Roles of Socioeconomic Status and Provider Density
12. Updating the Know Your Chances Website to Include Smoking Status as a Risk Factor for Mortality Estimates
13. Interpreting cancer incidence trends: challenges due to the COVID-19 pandemic
14. Using the Past to Understand the Future of U.S. and Global Smoking Disparities: A Birth Cohort Perspective
15. Evidence-based sizing of non-inferiority trials using decision models
16. Key Points for Clinicians About the SEER Oral Cancer Survival Calculator.
17. A New Personalized Oral Cancer Survival Calculator to Estimate Risk of Death From Both Oral Cancer and Other Causes.
18. Supplementary figure from Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends
19. Supplementary Figure Legends from Use of Multiple Imputation to Correct for Bias in Lung Cancer Incidence Trends by Histologic Subtype
20. Supplementary Materials and Methods and Supplementary Figure 1 through 10 from Exploring the Recent Trend in Esophageal Adenocarcinoma Incidence and Mortality Using Comparative Simulation Modeling
21. Data from Exploring the Recent Trend in Esophageal Adenocarcinoma Incidence and Mortality Using Comparative Simulation Modeling
22. Data from Use of Multiple Imputation to Correct for Bias in Lung Cancer Incidence Trends by Histologic Subtype
23. Supplementary Figure 1 from Use of Multiple Imputation to Correct for Bias in Lung Cancer Incidence Trends by Histologic Subtype
24. Legend for Supplementary Figure 1 from Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends
25. Supplementary Table 1 from Use of Multiple Imputation to Correct for Bias in Lung Cancer Incidence Trends by Histologic Subtype
26. Supplementary Table 2 from Use of Multiple Imputation to Correct for Bias in Lung Cancer Incidence Trends by Histologic Subtype
27. Risk Model–Based Lung Cancer Screening
28. Joinpoint Regression Methods of Aggregate Outcomes for Complex Survey Data.
29. Data-driven choice of a model selection method in joinpoint regression.
30. Developing Geographic Areas for Cancer Reporting Using Automated Zone Design
31. Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
32. The efficacy of prostate‐specific antigen screening: Impact of key components in the ERSPC and PLCO trials
33. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials
34. Joinpoint Regression Methods of Aggregate Outcomes for Complex Survey Data
35. Twenty years since Joinpoint 1.0: Two major enhancements, their justification, and impact
36. Data-driven choice of a model selection method in joinpoint regression
37. Additional file 1 of Estimating life expectancy adjusted by self-rated health status in the United States: national health interview survey linked to the mortality
38. On the choice of time scales in competing risks predictions
39. Impact of Joint Lung Cancer Screening and Cessation Interventions Under the New Recommendations of the U.S. Preventive Services Task Force
40. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening
41. Preliminary estimates of SEER cancer incidence for 2013
42. Updated Methodology for Projecting U.S.- and State-Level Cancer Counts for the Current Calendar Year: Part II: Evaluation of Incidence and Mortality Projection Methods
43. Characterizing Trends in Cancer Patients' Survival Using the JPSurv Software
44. Early Estimates of SEER Cancer Incidence for 2012: Approaches, Opportunities, and Cautions for Obtaining Preliminary Estimates of Cancer Incidence
45. A History of Health Economics and Healthcare Delivery Research at the National Cancer Institute.
46. Models in the Development of Clinical Practice Guidelines
47. Updated Methodology for Projecting U.S.- and State-Level Cancer Counts for the Current Calendar Year: Part I: Spatio-temporal Modeling for Cancer Incidence
48. Colorectal Cancer Screening
49. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography
50. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.